electroCore, Inc. announced promising data on the effectiveness of its gammaCore non-invasive vagus nerve stimulation (nVNS) device for treating concussive symptoms associated with mild traumatic ...

The Company is focused on commercializing medical devices for managing and treating certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human ...

and showed that the targeted fibers in the vagus nerve presumed to be stimulated by the gammaCore nVNS device are in fact activated as previously expected. Prof. Schoenen commented, "This study ...

nVNS, in treating concussive symptoms associated with mild traumatic brain injury. Dr. Michael Ament of Cherry Creek Neurology presented his study entitled, “Adjunctive Non-Invasive Vagus Nerve ...

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune ...